Cancer Epigenetics
Cancer Epigenetics: The research of epigenetic changes to the genome of disorder cells that do exclude an adjustment within the nucleotide grouping is referred to as most cancers Epigenetics. Epigenetic changes are as massive as hereditary adjustments in a cellular exchange to malignancy and their manage grasps fantastic potential for disorder avoidance, identification, and treatment. Assortments of mixes are considered as epigenetic most cancers-inflicting marketers, for instance, arsenite, diethylstilbestrol, hexachlorobenzene and nickel mixes. They create approximately an improved rate of tumors; however they do not display mutagen motion.
- DNA Methylation
- Histone modification
- MicroRNA gene silencing
- Epigenetic carcinogens
Related Conference of Cancer Epigenetics
August 22-23, 2022
2nd International Conference on Biomarkers and Clinical Research
Barcelona, Spain
September 12-12, 2022
36th International Conference on Cancer Science & Therapy
Amsterdam, Netherlands
September 23-24, 2022
17th World Congress on Biomarkers, Cancer Therapy & Clinical Research
Vancouver, Canada
September 24-25, 2022
3rd International Conference on Oncodiagnostics and Cancer Research
Vancouver, Canada
Cancer Epigenetics Conference Speakers
Recommended Sessions
- Alternative Treatments and Therapeutics
- Breast Cancer
- Cancer Biomarkers
- Cancer Biopsy
- Cancer Diagnosis and Screening
- Cancer Epidemiology
- Cancer Epigenetics
- Cancer Management and Prevention
- Cancer Metastasis
- Cancer Nanotechnology
- Cancer Pharmacology
- Cancer Science
- Cancer Therapy
- Hematology- Oncology
- Oncogenomics
- Oncology Nursing and Care
- Organic Specific Cancer
- Radiation Oncology
- Skin Cancer
- Stem cell Therapy
- Surgical Oncology
- Targeted Cancer Therapy
- Tumor Biology
- Tumor Immunology
- Tumor Virology
Related Journals
Are you interested in
- Cancer Metastasis - Cell Signaling 2022 (Canada)
- Advances in Cancer Detection - Euro Oncology 2022 (France)
- Advances in epigenetic technology - Epigenetics 2022 (Austria)
- Alternative and Complementary Medicine - BRECECAN 2022 (Spain)
- Alternative and Complimentary Therapies - ONCOLOGY MEET 2022 (UK)
- Antibody-based Therapeutics Against Cancer - Frontiers In Cancer 2022 (Japan)
- Anticancer drug - Preventive Oncology 2022 (Germany)
- Antineoplastic drugs - RADIOCANCER - 2022 (France)
- Bioinformatics and biostatics in epigenetic disease markers and targets - Epigenetics 2022 (Austria)
- Biomarkers - Biomarkers 2022 (Canada)
- Biomarkers Case Reports - Biomarkers 2022 (Canada)
- Biomarkers for Disorders - Biomarkers 2022 (Canada)
- Biomarkers in Clinical Research and Development - Biomarkers 2022 (Canada)
- Biomarkers in Drug Discovery - Biomarkers 2022 (Canada)
- Biomarkers in Market - Biomarkers 2022 (Canada)
- Biomarkers in Microbial Infections - Biomarkers 2022 (Canada)
- Biomarkers in Nanoscience - Biomarkers 2022 (Canada)
- Biomarkers in Toxicology - Biomarkers 2022 (Canada)
- Biomarkers of Exposure Response and Susceptibility - Biomarkers 2022 (Canada)
- Biomarkers: Entrepreneur Investments Meet - Biomarkers 2022 (Canada)
- Bladder Cancer - Euro Oncology 2022 (France)
- Brain Cancer - Euro Oncology 2022 (France)
- Brain Tumor - Epigenetics 2022 (Austria)
- Brain tumor - Preventive Oncology 2022 (Germany)
- Breast Cancer - BREAST CANCER MEET 2022 (UK)
- Breast Cancer - WOMEN ONCOLOGY 2022 (Thailand)
- Breast Cancer - Breast Cancer-2022 (Canada)
- Breast cancer - CANCER THERAPY MEETING 2022 (Australia)
- Breast Cancer and Cell Biology - BREAST CANCER MEET 2022 (UK)
- Breast Cancer and Genetics - Breast Cancer-2022 (Canada)
- Breast Cancer and Immunology - BREAST CANCER MEET 2022 (UK)
- Breast cancer and the Immune system - Breast Cancer-2022 (Canada)
- Breast Cancer Biology - BRECECAN 2022 (Spain)
- Breast Cancer Clinical Trials - Breast Cancer-2022 (Canada)
- Breast cancer detection, Prevention and diagnosis - Euro Oncology 2022 (France)
- Breast Cancer Detection, Prevention and Diagnosis - BREAST CANCER MEET 2022 (UK)
- Breast Cancer during pregnancy - BREAST CANCER MEET 2022 (UK)
- Breast Cancer Nursing - BRECECAN 2022 (Spain)
- Breast Cancer Nursing - Breast Cancer-2022 (Canada)
- Breast Cancer Nursing - BREAST CANCER MEET 2022 (UK)
- Breast Cancer Radiation Therapy - BREAST CANCER MEET 2022 (UK)
- Breast Cancer Recurrence - Breast Cancer-2022 (Canada)
- Breast Cancer Research - Frontiers In Cancer 2022 (Japan)
- Breast Cancer Risk - BREAST CANCER MEET 2022 (UK)
- Breast Cancer Risk Factors - Breast Cancer-2022 (Canada)
- Breast Cancer Surgery - BREAST CANCER MEET 2022 (UK)
- Breast Cancer Therapies - BREAST CANCER MEET 2022 (UK)
- Breast Cancer treatment - BREAST CANCER MEET 2022 (UK)
- Breast Cancer, Cancer Therapies And Breast Cancer Treatment - Women Oncology 2022 (Canada)
- Breast Cancer, Cancer Therapies And Breast Cancer Treatment - World Oncology 2022 (UAE)
- Breast Cancer: Clinical trials - BREAST CANCER MEET 2022 (UK)
- Breast Implants - Breast Cancer-2022 (Canada)
- Breast Microcalcifications - Breast Cancer-2022 (Canada)
- Breastfeeding and Breast Cancer - BRECECAN 2022 (Spain)
- Cancer & Therapeutics - RADIOLOGY AND ONCOLOGY 2022 (Spain)
- Cancer and Stem Cell Therapy - World Cancer 2022 (Switzerland)
- Cancer Awareness and Survival - WOMEN ONCOLOGY 2022 (Thailand)
- Cancer Awareness and Survival - World Cancer 2022 (Switzerland)
- Cancer Bioinformatics - Preventive Oncology 2022 (Germany)
- Cancer Bioinformatics - ONCOLOGY MEET 2022 (UK)
- Cancer Biology - RADIOCANCER - 2022 (France)
- Cancer Biology - Women Oncology 2022 (Canada)
- Cancer Biology - World Oncology 2022 (UAE)
- Cancer Biology - CANCER THERAPY MEETING 2022 (Australia)
- Cancer Biomarkers - WOMEN ONCOLOGY 2022 (Thailand)
- Cancer Biomarkers - Frontiers In Cancer 2022 (Japan)
- Cancer Biomarkers - Biomarkers 2022 (Canada)
- Cancer Biomarkers - Women Oncology 2022 (Canada)
- Cancer Biomarkers - Cell Signaling 2022 (Canada)
- Cancer Biomarkers - World Oncology 2022 (UAE)
- Cancer Biomarkers - Preventive Oncology 2022 (Germany)
- Cancer Biomarkers - CANCER THERAPY MEETING 2022 (Australia)
- Cancer Biomarkers - World Cancer 2022 (Switzerland)
- Cancer Biopsy - World Cancer 2022 (Switzerland)
- Cancer Cell Biology - CANCER SCIENCE CONGRESS 2022 (Netherlands)
- Cancer Cell Biology and Cancer Biomarker - RADIOLOGY AND ONCOLOGY 2022 (Spain)
- Cancer Cell Biology and Genetics - World Cancer 2022 (Switzerland)
- Cancer Cell Signaling - WOMEN ONCOLOGY 2022 (Thailand)
- Cancer Cell Signalling & Pathways - Frontiers In Cancer 2022 (Japan)
- Cancer Chemotherapy - CANCER THERAPY MEETING 2022 (Australia)
- Cancer Chemotherapy - World Cancer 2022 (Switzerland)
- Cancer Control & Population Health - WOMEN ONCOLOGY 2022 (Thailand)
- Cancer detection and diagnosis - ONCOLOGY MEET 2022 (UK)
- Cancer Development - Women Oncology 2022 (Canada)
- Cancer Development - World Oncology 2022 (UAE)
- Cancer Diagnostics: From Research to Clinical Practice - Frontiers In Cancer 2022 (Japan)
- Cancer Drugs - Euro Oncology 2022 (France)
- Cancer Drugs - Women Oncology 2022 (Canada)
- Cancer Drugs - World Oncology 2022 (UAE)
- Cancer drugs and vaccines - ONCOLOGY MEET 2022 (UK)
- Cancer Epidemiology - Frontiers In Cancer 2022 (Japan)
- Cancer Epidemiology - CANCER SCIENCE CONGRESS 2022 (Netherlands)
- Cancer Epidemiology - ONCOLOGY MEET 2022 (UK)
- Cancer Epidemiology - CANCER THERAPY MEETING 2022 (Australia)
- Cancer Epidemiology, Screening, Diagnosis & Prognosis - Women Oncology 2022 (Canada)
- Cancer Epidemiology, Screening, Diagnosis & Prognosis - World Oncology 2022 (UAE)
- Cancer Genetics - Cell Signaling 2022 (Canada)
- Cancer Genetics - CANCER SCIENCE CONGRESS 2022 (Netherlands)
- Cancer Genetics - CANCER THERAPY MEETING 2022 (Australia)
- Cancer Genetics & Epigenetics - Frontiers In Cancer 2022 (Japan)
- Cancer Genetics and Epigenetics - Cancer and Care 2022 (USA)
- Cancer Health Disparities - Women Oncology 2022 (Canada)
- Cancer Health Disparities - World Oncology 2022 (UAE)
- Cancer Immunology - ONCOLOGY MEET 2022 (UK)
- Cancer Immunology & Immunotherapy - Cancer and Care 2022 (USA)
- Cancer Immunology & Immunotherapy - CANCER SCIENCE CONGRESS 2022 (Netherlands)
- Cancer Immunology & Immunotherapy - Frontiers In Cancer 2022 (Japan)
- Cancer Immunotherapy & Vaccines - RADIOCANCER - 2022 (France)
- Cancer lifestyle and nutrition - ONCOLOGY MEET 2022 (UK)
- Cancer Metabolism - Frontiers In Cancer 2022 (Japan)
- Cancer Metabolomics - World Cancer 2022 (Switzerland)
- Cancer Metastasis - CANCER SCIENCE CONGRESS 2022 (Netherlands)
- Cancer Metastasis - Cancer and Care 2022 (USA)
- Cancer Metastasis - World Cancer 2022 (Switzerland)
- Cancer Mode of Existence - Preventive Oncology 2022 (Germany)
- Cancer Nanotechnology - World Cancer 2022 (Switzerland)
- Cancer nanotechnology - ONCOLOGY MEET 2022 (UK)
- Cancer Nanotechnology - CANCER SCIENCE CONGRESS 2022 (Netherlands)
- Cancer Nanotechnology - Preventive Oncology 2022 (Germany)
- Cancer Pathophysiology - ONCOLOGY MEET 2022 (UK)
- Cancer Pathophysiology - Preventive Oncology 2022 (Germany)
- Cancer Pharmacology - World Cancer 2022 (Switzerland)
- Cancer Pharmacology - CANCER SCIENCE CONGRESS 2022 (Netherlands)
- Cancer Pharmacology - ONCOLOGY MEET 2022 (UK)
- Cancer Pharmacology - RADIOLOGY AND ONCOLOGY 2022 (Spain)
- Cancer Pharmacology - CANCER THERAPY MEETING 2022 (Australia)
- Cancer Pharmacology & Cytopathology - Cell Signaling 2022 (Canada)
- Cancer Prevention - Frontiers In Cancer 2022 (Japan)
- Cancer Prevention & Research - CANCER THERAPY MEETING 2022 (Australia)
- Cancer prevention and Care - Cancer and Care 2022 (USA)
- Cancer Prevention and Research - World Cancer 2022 (Switzerland)
- Cancer Prevention and Research - RADIOLOGY AND ONCOLOGY 2022 (Spain)
- Cancer Preventive Vaccines: Oncolytic Therapy & Others - Women Oncology 2022 (Canada)
- Cancer Preventive Vaccines: Oncolytic Therapy & Others - World Oncology 2022 (UAE)
- Cancer Rehabilitation - RADIOCANCER - 2022 (France)
- Cancer Risk Factors - World Oncology 2022 (UAE)
- Cancer Risk Factors - Women Oncology 2022 (Canada)
- Cancer Science - CANCER SCIENCE CONGRESS 2022 (Netherlands)
- Cancer Science - Women Oncology 2022 (Canada)
- Cancer Science - World Oncology 2022 (UAE)
- Cancer Screening - WOMEN ONCOLOGY 2022 (Thailand)
- Cancer screening - Cancer and Care 2022 (USA)
- Cancer Screening and detection - ONCOLOGY MEET 2022 (UK)
- Cancer Stem Cells - Frontiers In Cancer 2022 (Japan)
- Cancer Stem Cells - Women Oncology 2022 (Canada)
- Cancer Stem cells - Cell Signaling 2022 (Canada)
- Cancer Stem Cells - World Oncology 2022 (UAE)
- Cancer Therapeutics - Cell Signaling 2022 (Canada)
- Cancer Therapeutics and Novel Approaches - Preventive Oncology 2022 (Germany)
- Cancer Therapy - Preventive Oncology 2022 (Germany)
- Cancer Therapy - CANCER SCIENCE CONGRESS 2022 (Netherlands)
- Cancer Therapy & Treatments - Frontiers In Cancer 2022 (Japan)
- Cancer Therapy & Treatments - CANCER THERAPY MEETING 2022 (Australia)
- Cancer Therapy, Prevention and Medicine - BRECECAN 2022 (Spain)
- Cancer Treatment - Women Oncology 2022 (Canada)
- Cancer Treatment - World Oncology 2022 (UAE)
- Cancer treatment and therapies - ONCOLOGY MEET 2022 (UK)
- Cancer Vaccines - Women Oncology 2022 (Canada)
- Cancer Vaccines - World Oncology 2022 (UAE)
- Cancer Vaccines - World Cancer 2022 (Switzerland)
- Cancer Vaccines - Cell Signaling 2022 (Canada)
- Cancer Vaccines - Frontiers In Cancer 2022 (Japan)
- Cancer Vaccines - Cancer and Care 2022 (USA)
- Cancer: Lifestyle Connection and Nutrition - World Cancer 2022 (Switzerland)
- Cancer: Psychological and Social Aspects - World Cancer 2022 (Switzerland)
- Cancer: Psychological Aspects - WOMEN ONCOLOGY 2022 (Thailand)
- Cancers of specific organs - RADIOCANCER - 2022 (France)
- Carcinogenesis. - Frontiers In Cancer 2022 (Japan)
- Carcinogens in cosmetics - RADIOCANCER - 2022 (France)
- Cardio Oncology - Women Oncology 2022 (Canada)
- Cardio Oncology - World Oncology 2022 (UAE)
- Cell & Gene Therapy - Cell Signaling 2022 (Canada)
- Cell Biology - Cell Signaling 2022 (Canada)
- Cell biology of cancer - Preventive Oncology 2022 (Germany)
- Cell Metabolism - Cell Signaling 2022 (Canada)
- Cell Signaling - Cell Signaling 2022 (Canada)
- Cervical Cancer - WOMEN ONCOLOGY 2022 (Thailand)
- Cervical Cancer Biology - BRECECAN 2022 (Spain)
- Chemotherapy - WOMEN ONCOLOGY 2022 (Thailand)
- Chromatin analysis - Epigenetics 2022 (Austria)
- Chromatin domains and structure - Epigenetics 2022 (Austria)
- Circulating Tumor Cell (CTC) - Women Oncology 2022 (Canada)
- Circulating Tumor Cell (CTC) - World Oncology 2022 (UAE)
- Circulating Tumor Cells - Frontiers In Cancer 2022 (Japan)
- Clinical Neonatology - NEONATAL ONCOLOGY 2022 (Japan)
- Clinical Pediatrics - NEONATAL ONCOLOGY 2022 (Japan)
- Colorectal Cancer - Euro Oncology 2022 (France)
- Colorectal Cancer Progression - Frontiers In Cancer 2022 (Japan)
- Complementary & Alternative Methods and Cancer - CANCER THERAPY MEETING 2022 (Australia)
- Complementary and Alternative Methods and Cancer - World Cancer 2022 (Switzerland)
- Computational Analysis of Cancer - Frontiers In Cancer 2022 (Japan)
- Computational modeling - Epigenetics 2022 (Austria)
- COVID-19 and its impact on Cancer patients - Frontiers In Cancer 2022 (Japan)
- Current Research Concepts in Biomarkers - Biomarkers 2022 (Canada)
- Diet and lifestyle effect on Breast Cancer - BREAST CANCER MEET 2022 (UK)
- DNA & RNA sequencing - Epigenetics 2022 (Austria)
- Drug Resistance - Frontiers In Cancer 2022 (Japan)
- Endometrial Cancer - WOMEN ONCOLOGY 2022 (Thailand)
- Environmental Epigenetic Factor - Epigenetics 2022 (Austria)
- Epidemiology of breast cancer and Risk Factors - BREAST CANCER MEET 2022 (UK)
- Epigenetics - Epigenetics 2022 (Austria)
- Epigenetics and epigenomics - Epigenetics 2022 (Austria)
- Epigenetics and stem cell reprogramming - Epigenetics 2022 (Austria)
- Epigenetics in bacteria - Epigenetics 2022 (Austria)
- Epigenetics in cancer - Preventive Oncology 2022 (Germany)
- Epigenetics in psychology and psychiatry - Epigenetics 2022 (Austria)
- Epigenetics Reproductive Health - Epigenetics 2022 (Austria)
- Epigenome and transcriptome editing - Epigenetics 2022 (Austria)
- Fragment analysis - Epigenetics 2022 (Austria)
- Functional Genomics and Cytogenetic Biomarkers - Biomarkers 2022 (Canada)
- Functional Transcriptomics and Profiling Techniques - Biomarkers 2022 (Canada)
- Functions and consequences: development and transgenerational - Epigenetics 2022 (Austria)
- Gastrointestinal cancer - Preventive Oncology 2022 (Germany)
- General tests for Brest Cancer - BRECECAN 2022 (Spain)
- Genetic Mutations Of Cancer - Women Oncology 2022 (Canada)
- Genetic Mutations Of Cancer - World Oncology 2022 (UAE)
- Genomes editing - Epigenetics 2022 (Austria)
- Genomic Medicine - ONCOLOGY MEET 2022 (UK)
- Gerson therapy - Preventive Oncology 2022 (Germany)
- Gynaecologic Oncology - Euro Oncology 2022 (France)
- Gynaecological cancers - RADIOCANCER - 2022 (France)
- Gynecologic Oncology - Women Oncology 2022 (Canada)
- Gynecologic Oncology - World Oncology 2022 (UAE)
- Haematology - ONCOLOGY MEET 2022 (UK)
- Hematological Cancers - RADIOCANCER - 2022 (France)
- Hematological Tumors - Frontiers In Cancer 2022 (Japan)
- Hormone replacement therapy - ONCOLOGY MEET 2022 (UK)
- Immune Responses & DNA Repair – Cancer Fields - Frontiers In Cancer 2022 (Japan)
- Immunology and Breast Cancer - BRECECAN 2022 (Spain)
- Immunotherapy - CANCER THERAPY MEETING 2022 (Australia)
- Inflammatory Breast Cancer - BREAST CANCER MEET 2022 (UK)
- Innovations of Cancer Research and Oncology - ONCOLOGY MEET 2022 (UK)
- Innovative Cancer Science: Translating Biology to Medicine - Frontiers In Cancer 2022 (Japan)
- Integrative care - WOMEN ONCOLOGY 2022 (Thailand)
- Interventional Radiology - RADIOLOGY AND ONCOLOGY 2022 (Spain)
- Key role of Pathology in cancer - Euro Oncology 2022 (France)
- Lifestyle and Nutrition for Cancer - Cancer and Care 2022 (USA)
- Liver Cancer - CANCER THERAPY MEETING 2022 (Australia)
- Lung Cancer - Frontiers In Cancer 2022 (Japan)
- Lung Cancer - Preventive Oncology 2022 (Germany)
- Lung Cancer - WOMEN ONCOLOGY 2022 (Thailand)
- Magnetic Resonance Imaging (MRI) - RADIOLOGY AND ONCOLOGY 2022 (Spain)
- Male Breast Cancer Research - BREAST CANCER MEET 2022 (UK)
- Mammography - BREAST CANCER MEET 2022 (UK)
- Mastectomy - BREAST CANCER MEET 2022 (UK)
- Measurement and mapping of genomic - Epigenetics 2022 (Austria)
- Medical Imaging Technology - RADIOLOGY AND ONCOLOGY 2022 (Spain)
- Metastatic Breast Cancer - BREAST CANCER MEET 2022 (UK)
- Metastatic Cancer - Preventive Oncology 2022 (Germany)
- Mylenoma - RADIOCANCER - 2022 (France)
- Nanopore Sequencing of Cancer Genomics - Frontiers In Cancer 2022 (Japan)
- Nanotechnology / Nanomedicines in Cancer Treatment - BRECECAN 2022 (Spain)
- Nanotechnology In Cancer Treatment - Women Oncology 2022 (Canada)
- Nanotechnology In Cancer Treatment - World Oncology 2022 (UAE)
- Neonatal & Pediatric Endocrinology - NEONATAL ONCOLOGY 2022 (Japan)
- Neonatal & Pediatric Hematology - NEONATAL ONCOLOGY 2022 (Japan)
- Neonatal & Pediatric Imaging - NEONATAL ONCOLOGY 2022 (Japan)
- Neonatal & Pediatric Immunology - NEONATAL ONCOLOGY 2022 (Japan)
- Neonatal & Pediatric leukemia - NEONATAL ONCOLOGY 2022 (Japan)
- Neonatal & Pediatric Nutrition - NEONATAL ONCOLOGY 2022 (Japan)
- Neonatal & Pediatric Oncology - NEONATAL ONCOLOGY 2022 (Japan)
- Neonatal & Pediatric Oncology Diagnosis - NEONATAL ONCOLOGY 2022 (Japan)
- Neonatal & Pediatric Pulmonology - NEONATAL ONCOLOGY 2022 (Japan)
- Neonatal & Pediatric Radiology - NEONATAL ONCOLOGY 2022 (Japan)
- Neonatal And Pediatric Oncology - World Oncology 2022 (UAE)
- Neonatal and Pediatric Oncology - World Cancer 2022 (Switzerland)
- Neonatal And Pediatric Oncology - Women Oncology 2022 (Canada)
- Neonatology & Pediatrics - NEONATAL ONCOLOGY 2022 (Japan)
- Neuro-oncology - Preventive Oncology 2022 (Germany)
- Neuro-oncology: focuses on cancers of brain - Epigenetics 2022 (Austria)
- Neuroblastoma - NEONATAL ONCOLOGY 2022 (Japan)
- Neuroradiology and Neuro Oncology - RADIOLOGY AND ONCOLOGY 2022 (Spain)
- Next Generation Cancer Models - Frontiers In Cancer 2022 (Japan)
- Novel Approaches to Cancer Therapeutics - BRECECAN 2022 (Spain)
- Nucleosome positioning - Epigenetics 2022 (Austria)
- Nutritional Biomarkers - Biomarkers 2022 (Canada)
- Omics Technologies in Biomarkers Discovery and Validation - Biomarkers 2022 (Canada)
- Oncologists: Biomarkers - Biomarkers 2022 (Canada)
- Oncology - WOMEN ONCOLOGY 2022 (Thailand)
- Oncology - Epigenetics 2022 (Austria)
- Oncology Nursing - Women Oncology 2022 (Canada)
- Oncology nursing - Preventive Oncology 2022 (Germany)
- Oncology Nursing - World Oncology 2022 (UAE)
- Oncology Nursing - WOMEN ONCOLOGY 2022 (Thailand)
- Oncology Nursing and Care - World Cancer 2022 (Switzerland)
- Oncology Nursing and Care - RADIOLOGY AND ONCOLOGY 2022 (Spain)
- Oncology Research - World Oncology 2022 (UAE)
- Oncology Research - Women Oncology 2022 (Canada)
- Oncology research categories - ONCOLOGY MEET 2022 (UK)
- Oncology: Sub-Specialities - CANCER THERAPY MEETING 2022 (Australia)
- Oncology: Sub-Specialties - World Cancer 2022 (Switzerland)
- Ophthalmic Oncology - Euro Oncology 2022 (France)
- Organ Specific Cancer - Women Oncology 2022 (Canada)
- Organ Specific Cancer - World Oncology 2022 (UAE)
- Organ Specific Cancer - Cancer and Care 2022 (USA)
- Organ-Defined Cancers - Frontiers In Cancer 2022 (Japan)
- Organ-Defined Cancers - CANCER THERAPY MEETING 2022 (Australia)
- Organ-Defined Cancers - World Cancer 2022 (Switzerland)
- Other Cancers - BREAST CANCER MEET 2022 (UK)
- Ovarian Cancer - WOMEN ONCOLOGY 2022 (Thailand)
- Palliative Care - ONCOLOGY MEET 2022 (UK)
- Palliative care for Cancer - NEONATAL ONCOLOGY 2022 (Japan)
- Pediatric Dermatology - NEONATAL ONCOLOGY 2022 (Japan)
- Pediatric Neuro Oncology - NEONATAL ONCOLOGY 2022 (Japan)
- Pediatric Oncology - Euro Oncology 2022 (France)
- Pediatric Oncology Nursing - NEONATAL ONCOLOGY 2022 (Japan)
- Personalized Medicine and Data Analysis - Biomarkers 2022 (Canada)
- Phases And Types Of Clinical Trails - World Oncology 2022 (UAE)
- Phases And Types Of Clinical Trails - Women Oncology 2022 (Canada)
- Plants Against Cancer - Preventive Oncology 2022 (Germany)
- Precision Cancer Medicine & Oncology - CANCER THERAPY MEETING 2022 (Australia)
- Precision Medicine And Immuno-Oncology - World Oncology 2022 (UAE)
- Precision Medicine And Immuno-Oncology - Women Oncology 2022 (Canada)
- Protein interaction analysis - Epigenetics 2022 (Austria)
- Protein Signaling & Neuronal Signaling - Cell Signaling 2022 (Canada)
- Pulmonary Oncology - Women Oncology 2022 (Canada)
- Pulmonary Oncology - World Oncology 2022 (UAE)
- Radiation & Chemotherapy - Cell Signaling 2022 (Canada)
- Radiation oncology - Preventive Oncology 2022 (Germany)
- Radiation Oncology - CANCER SCIENCE CONGRESS 2022 (Netherlands)
- Radiation Oncology - Women Oncology 2022 (Canada)
- Radiation Oncology - Euro Oncology 2022 (France)
- Radiation Oncology - Frontiers In Cancer 2022 (Japan)
- Radiation Oncology - World Oncology 2022 (UAE)
- Radiation Oncology Nursing - Euro Oncology 2022 (France)
- Radiation Therapy - WOMEN ONCOLOGY 2022 (Thailand)
- Radiation Therapy for Cancer - RADIOCANCER - 2022 (France)
- Radiology - BREAST CANCER MEET 2022 (UK)
- Radiology Trends and Technology - RADIOLOGY AND ONCOLOGY 2022 (Spain)
- Radiology Trends and Technology - Euro Oncology 2022 (France)
- Radiology/Cancer Imaging - Frontiers In Cancer 2022 (Japan)
- Radiopharmaceuticals - RADIOLOGY AND ONCOLOGY 2022 (Spain)
- Radiotherapy - CANCER THERAPY MEETING 2022 (Australia)
- Radiotherapy and Chemotherapy - RADIOLOGY AND ONCOLOGY 2022 (Spain)
- Reconstruction of breast cancer - Breast Cancer-2022 (Canada)
- Retinoblastoma - RADIOCANCER - 2022 (France)
- RNA transcripts, MicroRNAs, mRNA, and sRNA - Epigenetics 2022 (Austria)
- Robotic surgery for cancer treatment - Preventive Oncology 2022 (Germany)
- Screening tests - Preventive Oncology 2022 (Germany)
- Screening, Detecting and Diagnosing - BRECECAN 2022 (Spain)
- Signal Transduction - Cell Signaling 2022 (Canada)
- Signaling Pathways & Diseases - Cell Signaling 2022 (Canada)
- Single-cell and Spatial Multiomics in Cancer Research - Frontiers In Cancer 2022 (Japan)
- Skin Cancer - Preventive Oncology 2022 (Germany)
- Skin cancers - Frontiers In Cancer 2022 (Japan)
- Solid Tumors - Frontiers In Cancer 2022 (Japan)
- Stages of Cancer - ONCOLOGY MEET 2022 (UK)
- Stem Cell Therapy - CANCER SCIENCE CONGRESS 2022 (Netherlands)
- Structural inheritance - Epigenetics 2022 (Austria)
- Surgeries involved in Breast Cancer - Breast Cancer-2022 (Canada)
- Surgery Choices for Breast Cancer - BRECECAN 2022 (Spain)
- Surgical oncology - Preventive Oncology 2022 (Germany)
- Surgical Oncology - Frontiers In Cancer 2022 (Japan)
- Techniques to Maximize Biomarker Identification - Biomarkers 2022 (Canada)
- The Application of Clinical Proteomics for Precision Oncology - Frontiers In Cancer 2022 (Japan)
- Therapies in Neonatal & Pediatric Oncology - NEONATAL ONCOLOGY 2022 (Japan)
- Treating Breast Cancer with Chemotherapy - Breast Cancer-2022 (Canada)
- Tumor Heterogeneity and Cancer Metastasis - Frontiers In Cancer 2022 (Japan)
- Tumor virology - Preventive Oncology 2022 (Germany)
- Tumor Virology, Immunology and Cellular Pathology - World Cancer 2022 (Switzerland)
- Tumors heterogeneity - Preventive Oncology 2022 (Germany)
- Tumour Microenvironment - Frontiers In Cancer 2022 (Japan)
- Tumour screening and clinical management - RADIOCANCER - 2022 (France)
- Types of Cancer - ONCOLOGY MEET 2022 (UK)
- Types Of Cancers - Women Oncology 2022 (Canada)
- Types Of Cancers - World Oncology 2022 (UAE)
- Veterinary Oncology - World Oncology 2022 (UAE)
- Veterinary Oncology - Women Oncology 2022 (Canada)
- Women’s Health and Contraception - BRECECAN 2022 (Spain)